HS Icon Unpackaged Medicaments

3003 (Harmonized System 1992 for 4-digit)

Overview This page contains the latest trade data of Unpackaged Medicaments. In 2019, Unpackaged Medicaments were the world's 290th most traded product, with a total trade of $11.5B. Between 2018 and 2019 the exports of Unpackaged Medicaments decreased by -36.1%, from $18B to $11.5B. Trade in Unpackaged Medicaments represent 0.063% of total world trade.

Exports In 2019 the top exporters of Unpackaged Medicaments  were Netherlands ($2.38B), United States ($1.27B), Germany ($797M), China ($768M), and Switzerland ($635M).

Imports In 2019 the top importers of Unpackaged Medicaments were United Kingdom ($2.34B), Ireland ($1.32B), Germany ($803M), United States ($631M), and Netherlands ($473M).

Tariffs In 2018 the average tariff for Unpackaged Medicaments was 3.99%, making it the 997th lowest tariff using the HS4 product classification.

The countries with the highest import tariffs for Unpackaged Medicaments are Iran (34.5%), Nepal (14.1%), Morocco (11.6%), Pakistan (10.8%), and Tunisia (10%). The countries with the lowest tariffs are Angola (0%), Cote d'Ivoire (0%), Ghana (0%), Guinea (0%), and Kenya (0%).

Ranking Unpackaged Medicaments ranks 383rd in the Product Complexity Index (PCI).

Description Examples of medicaments consisting of two or more constituents mixed together for therapeutic or prophylactic uses are antibiotics, which are used to treat bacterial infections, and vaccines, which are used to prevent diseases.

Historical Data

#permalink to section

Exporters and Importers

#permalink to section

Trade By Country

Top Origin (2019): Netherlands, $2.38B

Top Destination (2019): United Kingdom, $2.34B

Unpackaged Medicaments are the world's 290th most traded product.

In 2019, the top exporters of Unpackaged Medicaments were Netherlands ($2.38B), United States ($1.27B), Germany ($797M), China ($768M), and Switzerland ($635M).

In 2019, the top importers of Unpackaged Medicaments were United Kingdom ($2.34B), Ireland ($1.32B), Germany ($803M), United States ($631M), and Netherlands ($473M).

Explore Visualizations

Market Dynamics

#permalink to section

Trade by country

Value

Top Origin Growth (2018 -  2019): Netherlands, $633M

Top Destination Growth (2018 - 2019): United Kingdom, $366M

Between 2018 and 2019, the exports of Unpackaged Medicaments grew the fastest in Netherlands ($633M), Switzerland ($123M), Portugal ($102M), Denmark ($63.2M), and Sweden ($43.7M).

Between 2018 and 2019, the fastest growing importers of Unpackaged Medicaments were United Kingdom ($366M), Russia ($128M), Spain ($115M), Portugal ($44.6M), and Denmark ($43.9M).

Explore Visualizations

Market Concentration

#permalink to section

Cumulative market share

Value

This chart shows the evolution of the market concentration of exports of Unpackaged Medicaments.

In 2019,  market concentration measured using Shannon Entropy, was 4.48. This means that most of the exports of Unpackaged Medicaments are explained by 22 countries.

Explore Visualizations

This map shows which countries export or import more of Unpackaged Medicaments. Each country is colored based on the difference in exports and imports of Unpackaged Medicaments during 2019.

Disaggregation

#permalink to section
Value

In 2019, the world most traded Unpackaged Medicaments, disaggragated by their HS6 level were Medicaments nes, formulated, in bulk ($8.94B), Antibiotics nes, formulated, in bulk ($1.1B), Hormones nes, no antibiotics, bulk, not... ($768M), Penicillins or streptomycins and derivatives, in... ($372M), and Alkaloids, derivs, without antibiotics, hormones, bul ($243M)

Import Tariffs

#permalink to section

In 2018, the average tariff for importing Unpackaged Medicaments was 3.99%. The countries with the highest tariffs for importing Unpackaged Medicaments were Iran (34.5%), Nepal (14.1%), Morocco (11.6%), Pakistan (10.8%), and Tunisia (10%).

Product Complexity

#permalink to section

Diversification Frontier

#permalink to section
Specialization

The Complexity-Relatedness diagram compares the risk and the strategic value of a product's potential export opportunities. Relatedness is predictive of the probability that a country increases its exports in a product. Complexity, is associated with higher levels of income, economic growth potential, lower income inequality, and lower emissions.

Country by Relatedness

#permalink to section

The following visualization shows the relatedness of Unpackaged Medicaments to countries. Higher relatedness values ​​indicate greater knowledge, which predicts a greater probability of exporting that product in the future.